The role of nitric oxide in mediating tumour blood flow.
about
Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and TransformationInhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows.Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.
P2860
The role of nitric oxide in mediating tumour blood flow.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of nitric oxide in mediating tumour blood flow.
@ast
The role of nitric oxide in mediating tumour blood flow.
@en
type
label
The role of nitric oxide in mediating tumour blood flow.
@ast
The role of nitric oxide in mediating tumour blood flow.
@en
prefLabel
The role of nitric oxide in mediating tumour blood flow.
@ast
The role of nitric oxide in mediating tumour blood flow.
@en
P2093
P2860
P1476
The role of nitric oxide in mediating tumour blood flow.
@en
P2093
Anthony D Yang
E Ramsay Camp
George Van Buren
Lee M Ellis
Michael J Gray
Ray Somcio
P2860
P304
P356
10.1517/14728222.10.5.689
P407
P577
2006-10-01T00:00:00Z